-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Raymond James Maintains Strong Buy on AngioDynamics, Lowers Price Target to $22

Benzinga · 01/06/2023 07:27
Raymond James analyst Jayson Bedford maintains AngioDynamics (NASDAQ:ANGO) with a Strong Buy and lowers the price target from $25 to $22.